Description
One of Kalorama’s best-selling market research reports, this report provides the reader with a complete analysis of the domestic and international markets for pharmaceuticals to treat skin diseases and disorders. This edition of Worldwide Market for Prescription Dermatological Drugs is the sixth time Kalorama Information has comprehensively studied the dermatology markets.
Kalorama has completely re-evaluated the market from the ground up, and in addition to the usual primary research (interviews) of industry participants, clinicians, and regulators, we also conducted scores of interviews with users of Kalorama’s 2004 and 2006 dermatological studies to ensure that the current report contains the best possible data and the most useful analysis.
In this new edition, various shifts in the market are noted. There is information on bilogics, discussion of fillers and of treatments for skin infections such as MRSA. New companies have been added and consolidations in the industry have been addressed.
Market information is available for the years 2004 to 2011, with the focus year 2006 for competitive analysis. Overview and product descriptions of general therapy segments are covered, including prescription drugs to treat:
- Acne and Rosacea
- Antiaging and Photodamage
- Dermatitis and Seborrhea
- Fungal Infections
- Hair Loss and Hair Removal
- Hyperpigmentation/Melasma
- Psoriasis
- Skin Cancer, and
- Other Skin Disorders
Other data points include competitive market share, demographics, epidemiology, and geographic break down, which provide revenues for four regions:
- United States
- Europe
- Japan
- Rest of world
The study covers issues and trends affecting the market, research and developments, and more. In particular, the study explores the current and potential effects of the aging baby boomers on the prescription dermatology market and the continued demand for lifestyle drugs. Profiles of major market participants are included, including:
- Allergan Inc.
- Allergan Inamed Corporation
- Barrier Therapeutics, Inc
- Bayer AG
- Bradley Pharmaceuticals, Inc
- Bristol-Myers Squibb
- CollaGenex Pharmaceuticals
- Galderma S.A.
- Genentech, Inc.
- GlaxoSmithKline Plc
- Johnson & Johnson (Janssen Pharmaceutica, Ortho Dermatological, Ortho-McNeil)
- Medicis Pharmaceutical Corporation
- Merck & Company, Inc.
- Mylan Pharmaceuticals, Inc,
- Novartis Pharmaceuticals Corporation
- Nycomed Inc.
- Pfizer, Inc.
- Q-Med AB
- Roche Group (F. Hoffmann-La Roche Ltd.)
- Schering-Plough Corporation
- Sinclair Pharma Plc.
- SkinMedica
- Stiefel Laboratories, Inc.
- Valeant Pharmaceuticals, Inc.
Table of Contents
Chapter One: Executive Summary
- Size and Growth of the Market
- Issues and Trends Affecting Market
Chapter Two: Introduction
- Structure and Function of the Skin
- Effects of Aging on the Skin
- Dermatological Conditions and Treatment
- Demographics of Skin Disorders, Incidence, and Prevalence
Chapter Three: Issues and Trends
- Melanoma Survival Rates Falter
- Genetic Link to Psoriasis
- Importance of Drug Delivery
Chapter Four: Prescription Antiacne and Rosacea Drugs
- All-trans Retinoic Acid (Tretinoin)
- Markets by Geographical Region
Chapter Five: Prescription Antiaging and Photodamage Drugs
- Markets by Geographical Region
Chapter Six: Prescription Dermatitis and Seborrhea Drugs
- Markets by Geographical Region
Chapter Seven: Prescription Antifungal Drugs
- Allylamines and Benzylamines
- Other Topical Formulations
- Markets by Geographical Region
Chapter Eight: Prescription Hair Loss and Hair Removal Drugs
- Markets by Geographical Region
Chapter Nine: Prescription Hyperpigmentation/Melasma Drugs
- Markets by Geographical Region
Chapter Ten: Prescription Psoriasis Drugs
- Topical Psoriasis Products
- Second-generation Retinoids
- Systemic Psoriasis Preparations
- Olopatadine Hydrochloride
- Markets by Geographical Region
Chapter Eleven: Prescription Skin Cancer Drugs
- Cutaneous T-cell Lymphoma
- Dysplastic Nevus Syndrome
- Mechlorethamine/Nitrogen Mustard
- Carmustine/BCNU (Topical)
- Vinblastine (Intralesional) and Others
- Markets by Geographical Region
Chapter Twelve: Miscellaneous Skin Disorder Drugs—Antivirals and Antiparasitics
- Markets by Geographical Region
Chapter Thirteen: World Market Summary
- Total Market Size and Forecast
- Market and Competitive Analysis
Chapter Fourteen: Corporate Profiles
- Allergan Inamed Corporation
- Barrier Therapeutics, Inc
- Bradley Pharmaceuticals, Inc
- CollaGenex Pharmaceuticals
- Johnson & Johnson (Janssen Pharmaceutica, Ortho Dermatological, Ortho-McNeil)
- Medicis Pharmaceutical Corporation
- Mylan Pharmaceuticals, Inc,
- Novartis Pharmaceuticals Corporation
- Roche Group (F. Hoffmann-La Roche Ltd.)
- Schering-Plough Corporation
- Stiefel Laboratories, Inc.
- Valeant Pharmaceuticals, Inc.
Appendix: Company Directory
List of Exhibits
Chapter One: Executive Summary
- Table 1-1: The Global Market for Prescription Dermatological Drugs 2002, 2006, and 2011
- Figure 1-1: The Global Market for Prescription Dermatological Drugs 2002, 2006, and 2011
Chapter Two: Introduction
- Table 2-1: Common Bases for Topical Dermatological Medications
- Table 2-2: Worldwide Incidence and Prevalence of Selected Dermatologic Conditions
Chapter Three: Issues and Trends
- Table 3-1: Selected Dermatological Rx-to-OTC Switches
- Table 3-2: Selected Potential Prescription Dermatological Rx-to-OTC Switches
Chapter Four: Prescription Antiacne and Rosacea Drugs
- Table 4-1: Common Benzoyl Peroxide Formulations
- Table 4-2: Common Retinoid Formulations
- Table 4-3: Common Antibiotic Formulations
- Table 4-4: Common Oral Contraceptive Formulations
- Table 4-5: Prescription Acne and Rosacea Formulations in Development
- Table 4-6: The Global Market for Prescription Acne and Rosacea Drugs by Type 2002-2011
- Figure 4-1: The Global Market for Prescription Acne and Rosacea Drugs Revenues by Type 2000-2010
- Figure 4-2: The Global Market for Prescription Acne and Rosacea Drugs Share by Type 2006
- Figure 4-3: The Global Market for Prescription Acne and Rosacea Drugs Share by Type 2011
- Table 4-8: The Global Market for Prescription Antiacne and Rosacea Drugs by Geographical Region 2000-2011
- Figure 4-4: The Global Market for Prescription Antiacne and Rosacea Drugs Revenues by Geographical Region 2000-2011
- Figure 4-5: The Global Market for Prescription Antiacne and Rosacea Drugs Share by Geographical Region 2006
- Figure 4-6: The Global Market for Prescription Antiacne and Rosacea Drugs Share by Geographical Region 2011
- Table 4-14: Global Market for Prescription Antiacne and Rosacea Drugs Revenues and Market Share by Supplier 2006
- Figure 4-7: Global Market for Acne and Rosacea Drugs Market Share by Leading Supplier 2006
Chapter Five: Prescription Antiaging and Photodamage Drugs
- Table 5-1: Common Prescription Keratolytic Formulations
- Table 5-2: Occlusive Moisturizers—Categories of Ingredients
- Table 5-3: Common Prescription Moisturizers
- Table 5-4: Common Prescription Retinoids for Antiaging and Photodamage
- Table 5-5: Common Prescription Sunscreens
- Table 5-6: Other Prescription Antiaging and Photodamage Products
- Table 5-8: The Global Market Antiaging and Photodamage Drugs by Type 2000-2011
- Figure 5-1: The Global Market for Antiaging and Photodamage Drugs Revenues by Type 2000-2011
- Figure 5-2: The Global Market for Antiaging and Photodamage Drugs Share by Type 2006
- Figure 5-3: The Global Market for Antiaging and Photodamage Drugs Share by Type 2011
- Table 5-10: The Global Market for Prescription Antiaging and Photodamage Drugs by Geographical Region 2000-2006
- Figure 5-4: The Global Market for Prescription Antiaging and Photodamage Drugs, Revenues by Geographical Region 2000-2011
- Figure 5-5: The Global Market for Antiaging and Photodamage Drugs Share by Geographical Region 2006
- Figure 5-6: The Global Market for Antiaging and Photodamage Drugs Share by Geographical Region 2011
- Table 5-16: Global Market for Prescription Antiaging and Photodamage Drugs Revenues and Market Share by Supplier 2006
- Figure 5-7: Global Market for Prescription Antiaging and Photodamage Drugs, Market Share by Leading Supplier 2006
Chapter Six: Prescription Dermatitis and Seborrhea Drugs
- Table 6-1: Common Prescription Topical Corticosteroid Preparations
- Table 6-2: Common Prescription Systemic Corticosteroids
- Table 6-3: Prescription Dermatitis Formulations in Development
- Table 6-4: The Global Market for Prescription Dermatitis and Seborrhea Drugs by Type 2000-2011
- Figure 6-1: The Global Market for Prescription Dermatitis and Seborrhea Drugs Revenues by Type 2002-2011
- Figure 6-2: The Global Market for Prescription Dermatitis and Seborrhea Drugs Share by Type 2006
- Figure 6-3: The Global Market for Prescription Dermatitis and Seborrhea Drugs Share by Type 2011
- Table 6-6: The Global Market for Prescription Dermatitis and Seborrhea Drugs by Geographical Region 2002-2011
- Figure 6-4: The Global Market for Prescription Dermatitis and Seborrhea Drugs Revenues by Geographical Region 2002-2011
- Figure 6-5: The Global Market for Prescription Dermatitis and Seborrhea Drugs Share by Geographical Region 2006
- Figure 6-6: The Global Market for Prescription Dermatitis and Seborrhea Drugs Share by Geographical Region 2011
- Table 6-12: Global Market for Prescription Dermatitis and Seborrhea Drugs Revenues and Market Share by Supplier 2002
- Figure 6-7: Global Market for Prescription Dermatitis and Seborrhea Drugs Market Share by Leading Supplier 2006
Chapter Seven: Prescription Antifungal Drugs
- Table 7-1: Common Prescription Systemic Antifungal Dermatological Formulations
- Table 7-2: Common Prescription Topical Antifungal Dermatological Drugs
- Table 7-3: Prescription Antifungal Dermatological Drugs in Development
- Table 7-4: The Global Market for Prescription Antifungal Dermatological Drugs by Type 2002-2011
- Figure 7-1: The Global Market for Prescription Antifungal Dermatological Drugs Revenues by Type 2002-2011
- Figure 7-2: The Global Market for Prescription Antifungal Dermatological Drugs, Share by Type 2006
- Figure 7-3: The Global Market for Prescription Antifungal Dermatological Drugs, Share by Type 2011
- Table 7-6: The Global Market for Prescription Antifungal Dermatological Drugs by Geographical Region 2002-2006
- Figure 7-4: The Global Market for Prescription Antifungal Dermatological Drugs Revenues by Geographical Region 2002-2006
- Figure 7-5: The Global Market for Prescription Antifungal Dermatological Drugs, Share by Geographical Region 2006
- Figure 7-6: The Global Market for Prescription Antifungal Dermatological Drugs, Share by Geographical Region 2011
- Table 7-12: Global Market for Prescription Antifungal Dermatological Drugs Revenues and Market Share by Supplier 2006
- Figure 7-7: Global Market for Prescription Antifungal Dermatological
- Drugs Market Share by Leading Supplier 2006
Chapter Eight: Prescription Hair Loss and Hair Removal Drugs
- Table 8-1: Common Prescription Hair Loss or Hair Removal Formulations
- Table 8-2: Prescription Hair Loss or Hair Removal Formulations in Development
- Table 8-3: The Global Market for Prescription Hair Loss and Hair Removal Drugs by Type 2002-2011
- Figure 8-1: The Global Market for Prescription Hair Loss and Hair
- Removal Drugs Revenues by Type 2002-2011
- Figure 8-2: The Global Market for Prescription Hair Loss and Hair
- Removal Drugs, Share by Type 2006
- Figure 8-3: The Global Market for Prescription Hair Loss and Hair
- Removal Drugs, Share by Type 2011
- Table 8-5: The Global Market for Prescription Hair Loss and Hair
- Removal Drugs Revenues by Geographical Region 2002-2011
- Figure 8-4: The Global Market for Prescription Hair Loss and Hair
- Removal Drugs Revenues by Geographical Region 2002-2011
- Figure 8-5: The Global Market for Prescription Hair Loss and Hair
- Removal Drugs Share by Geographical Region 2006
- Figure 8-6: The Global Market for Prescription Hair Loss and Hair
- Removal Drugs Share by Geographical Region 2011
- Table 8-11: Global Market for Prescription Hair Loss and Hair Removal Drugs Revenues and Market Share by Supplier 2006
- Figure 8-7: Global Market for Prescription Hair Loss and Hair Removal Drugs Market Share by Leading Supplier 2006
Chapter Nine: Prescription Hyperpigmentation/Melasma Drugs
- Table 9-1: Common Prescription Hyperpigmentation/Melasma
- Table 9-2: Common Prescription Depigmenting Agents
- Table 9-3: The Global Market for Hyperpigmentation/Melasma Drugs by Type 2002-2012
- Figure 9-1: The Global Market for Hyperpigmentation/Melasma Drugs Revenues by Type 2002-2012
- Figure 9-2: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs, Share by Type 2006
- Figure 9-3: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs Share by Type 2011
- Table 9-5: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs by Geographical Region 2002-2011
- Figure 9-4: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs Revenues by Geographical Region 2002-2011
- Figure 9-5: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs, Share by Geographical Region 2006
- Figure 9-6: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs, Share by Geographical Region 2011
Chapter Ten: Prescription Psoriasis Drugs
- Table 10-1: Common Prescription Psoriasis Preparations
- Table 10-2: Prescription Psoriasis Preparations in Development
- Table 10-3: The Global Market for Prescription Psoriasis Drugs by Type 2002-2011
- Figure 10-1: The Global Market for Prescription Psoriasis Drugs Revenues by Type 2002-2011
- Figure 10-2: The Global Market for Prescription Psoriasis Drugs Share by Type 2006
- Figure 10-3: The Global Market for Prescription Psoriasis Drugs Share by Type 2011
- Table 10-5: The Global Market for Prescription Psoriasis Drugs by Geographical Region 2002-2011
- Figure 10-4: The Global Market for Prescription Psoriasis Drugs Revenues by Geographical Region 2002-2011
- Figure 10-5: The Global Market for Prescription Psoriasis Drugs Share by Geographical Region 2006
- Figure 10-6: The Global Market for Prescription Psoriasis Drugs Share by Geographical Region 2011
- Table 10-11: Global Market for Prescription Psoriasis Drugs Revenues and Market Share by Supplier 2006
- Figure 10-7: Global Market for Prescription Psoriasis Drugs Market Share by Leading Supplier 2006
Chapter Eleven: Prescription Skin Cancer Drugs
- Table 11-1: Malignant Conditions of the Skin
- Table 11-2: Common Prescription Topical and Intralesional Chemotherapeutic Agents
- Table 11-3: Prescription Skin Cancer Preparations in Development
- Table 11-4: The Global Market for Skin Cancer Drugs 2002-2011
- Figure 11-1: The Global Market for Skin Cancer Drugs 2002-2011
- Table 11-5: The Global Market for Prescription Skin Cancer Drugs by Geographical Region 2002-2011
- Figure 11-2: The Global Market for Prescription Skin Cancer Drugs Revenues by Geographical Region 2002-2011
- Figure 11-3: The Global Market for Prescription Skin Cancer Drugs
- Share by Geographical Region 2006
- Figure 11-4: The Global Market for Prescription Skin Cancer Drugs Share by Geographical Region 2011
- Table 11-12: Global Market for Prescription Skin Cancer Drugs Revenues and Market Share by Supplier 2006
- Figure 11-9: Global Market for Skin Cancer Drugs Market Share by Leading Supplier 2006
Chapter Twelve: Miscellaneous Skin Disorder Drugs—Antivirals and Antiparasitics
- Table 12-1: Common Prescription Topical Antiviral Formulations
- Table 12-2: Common Prescription Topical Antiparasitic Formulations
- Table 12-3: The Global Market for Prescription Miscellaneous Skin Disorder Drugs by Type 2002-2011
- Figure 12-1: The Global Market for Miscellaneous Skin Disorder Drugs Revenues by Type 2002-2006
- Table 12-5: The Global Market for Prescription Miscellaneous Drugs by Geographical Region 2002-2011
- Figure 12-2: The Global Market for Prescription Miscellaneous Drugs Revenues by Geographical Region 2002-2011
- Figure 12-3: The Global Market for Prescription Miscellaneous Drugs Share by Geographical Region 2006
- Figure 12-6: The Global Market for Prescription Miscellaneous Drugs Share by Geographical Region 2011
Chapter Thirteen: World Market Summary
- Table 13-1: The Global Market for Prescription Dermatological Drugs, Revenues by Segment, 2000-2011
- Figure 13-1: The Global Market for Prescription Dermatological Drugs Revenues by Dermatological Segment, 2002-2011
- Figure 13-2: The Global Market for Dermatological Drugs Market Share by Type 2006
- Figure 13-3: The Global Market for Prescription Dermatological Drugs Market Share by Type 2011
- Table 13-3: Global Market for Prescription Dermatological Drugs Revenues and Segments of Participation by Leading Market Participants 2006
